Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)

NCT00386425 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Sepsis

Interventions

DRUG: Drotrecogin alfa (activated)

Sponsor

Eli Lilly and Company